FDA Investigator Hector A Carrero

Hector A Carrero has inspections in 4 countries as of 29 Sep 2023. Hector A Carrero has collaborated with a combinined 2721 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Denmark, Germany, Hungary
Adam R Cooke, Amy H Ruble, Andrew A Hoopes, Andrey Sarafanov, PhD, Anissa M Cheung, Anthony R Bucks, Arulvathani P Arudchandran, Ashley A Mutawakkil, Barbara M Frazier, Barbara T Carmichael, Bei Y He, Bharat Khurana, Billy M Battles, Bo Chi, PhD, Bonita S Chester, Brett R Havranek, Brittany D Terhar, Burnell M Henry, Carl A Huffman, III, Carlos M Gonzalez, CDR Thomas R Berry, PPh, Charles L Zhou, Cherrie A Zachary, Christian D Lynch (CDL), Christine A Harman, PhD, Claire M Minden, Cody D Rickman, Constantin Y Philopoulos, Cynthia Jim, CSO, Damaris Y Hernandez, Darcel T Bigelow, David J Eide, Devaughn Edwards, Donald C Obenhuber, PhD, Donald L Myers, Dr. Carmelo Rosa, Dusty F Snoeberg, Ellen Huang, Eric M Mueller, PharmD, Eric M Padgett, Eric Peng, Erin C Hill, Gabriel R Mclemore, Gideon N Esuzor, Gwyn G Dickinson, Helen Y Saccone, Holly Brevig, Ivan E Reyes, Jacob G Lutz, Jacqueline Mdiaz Albertine, Jacqueline Mdiaz Albertini, James E Keller, PhD, James I Giefer, Janet B Abt, Jared P Stevens, Jason F Chancey, Jawaid Hamid, Jazmine N Still, Jeffrey D Meng, Jennifer D Hollstrom, Joseph A Piechocki, Joseph F Owens, Joseph George, Joseph R Lambert, Julie D Bringger, Justin A Boyd, Karen E D'orazio, Kathleen D Culver, Kathleen R Jones, PhD, Kelly K Nachtigal, Ken L Bowers, Kevin D Kallander, Kim Lthomas Cruse, Larry K Hampton, Laura M Ricles, Laurel A Beer, Lawrence Carter, III, Lisa R Hilliar, Margaret A Smithers, Margaret M Annes, Margaret Norton, Margret M Annes, Marie F Morin, Mary E Farbman, PhD, Matthew M Schuckmann, Matthew R Sleeter, Meihong Liu, Michael C Kennedy, PhD, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Michelle Y Clark Stuart, Mihaly S Ligmond, Monica Cburgos Garcia, Monica M Mcclure, Mra Davism, Nancy G Schmidt, Nutan Mytle, Obinna R Echeozo, Omotunde O Osunsanmi, Ou Ma, Pankaj H Amin, Paul A Bonneau, Paula A Trost, Penny H Mccarver, Perry H Gambrell, Pete Amin (Pankaj), Prabhu P Raju, Priscilla M Pastrana, Ralph H Vocque, Randy L Clarida, Rebecca E Dombrowski, Rhonda Alexander, Richard L Rutherford, Rita K Kabaso, Robert C Coleman, Robert J Ham, Robert W Jennings, Roger F Zabinski, Rose M Ashley, Sarah E Rhoades, Scott A Golladay, Sean R Bryd, Sean R Marcsisin, Seneca D Toms, Shafiq S Ahadi, Sheri L Stephenson, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Steven D Kehoe, Steven P Donald, Steven R Bauer, Susan M Jackson, Susan M Turcovski, Susanna E Ford, Analyst, Susant Hadman, Tamika D Cathey, Tammara A Stephens, Tara L Breckenridge, Tara L Greene, Teresita C Mercado, Thomas R Withers, Toyin B Oladimeji, Vicky C Stoakes, Victoria A Wagoner, Viviana Matta, Viviana R Ramirez, Walsworth, Yun Wu, PhD, Zhong Li, PhD, Zi Qiang Gu

Hector A Carrero's Documents

Publish Date Document Type Title
March, 2019 EIR IDT Biologika GmbH - EIR, 2019-03-08
March, 2019 FDA 483 Response IDT Biologika GmbH - Form 483R, 2019-03-25
April, 2018 FDA 483 Siwa Biotech Corp. - Form 483, 2018-04-27
March, 2019 FDA 483 IDT Biologika GmbH - Form 483, 2019-03-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more